APO Research
Talk to an analyst

APO RESEARCH · REPORT

Toxoid Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Toxoid Vaccines Industry Growth and Trends Forecast to 2032

22 December 2025105 pages

Choose your research edition.

Industry ResearchToxoid Vaccines Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Toxoid Vaccines Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Toxoid Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Toxoid Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Toxoid Vaccines Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Toxoid Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Toxoid Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Toxoid Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Toxoid Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Toxoid Vaccines include Shenzhen Kangtai Biological Products, Merck, Pfizer, GlaxoSmithKline, AstraZeneca, Sanofi Pasteur, Panacea Biotec, Emergent Biosolutions and Bharat Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Toxoid Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Toxoid Vaccines market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Toxoid Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Toxoid Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Toxoid Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Toxoid Vaccines Market by Company

Shenzhen Kangtai Biological Products

Merck

Pfizer

GlaxoSmithKline

AstraZeneca

Sanofi Pasteur

Panacea Biotec

Emergent Biosolutions

Bharat Biotech

Bausch Health

Astellas Pharma

Toxoid Vaccines Segment by Type

Tetanus

Monovalent Tetanus Toxoid (TT)

Pertussis (DTaP)

Diphtheria and Tetanus (DT)

Diphtheria

Toxoid Vaccines Segment by Application

Government Organizations

Hospitals And Clinics

Research

Others

Toxoid Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Toxoid Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Toxoid Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Toxoid Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Toxoid Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Toxoid Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tetanus Table 2. Major Company of Monovalent Tetanus Toxoid (TT) Table 3. Major Company of Pertussis (DTaP) Table 4. Major Company of Diphtheria and Tetanus (DT) Table 5. Major Company of Diphtheria Table 6. Global Toxoid Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Toxoid Vaccines Sales by Type (2021-2026) & (k units) Table 8. Global Toxoid Vaccines Sales Market Share in Volume by Type (2021-2026) Table 9. Global Toxoid Vaccines Sales by Type (2021-2026) & (US$ Million) Table 10. Global Toxoid Vaccines Sales Market Share in Value by Type (2021-2026) Table 11. Global Toxoid Vaccines Price by Type (2021-2026) & (US$/unit) Table 12. Global Toxoid Vaccines Sales by Type (2027-2032) & (k units) Table 13. Global Toxoid Vaccines Sales Market Share in Volume by Type (2027-2032) Table 14. Global Toxoid Vaccines Sales by Type (2027-2032) & (US$ Million) Table 15. Global Toxoid Vaccines Sales Market Share in Value by Type (2027-2032) Table 16. Global Toxoid Vaccines Price by Type (2027-2032) & (US$/unit) Table 17. North America Toxoid Vaccines Sales by Type (2021-2026) & (k units) Table 18. North America Toxoid Vaccines Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Toxoid Vaccines Sales by Type (2021-2026) & (k units) Table 20. Europe Toxoid Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Toxoid Vaccines Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Toxoid Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Toxoid Vaccines Sales by Type (2021-2026) & (k units) Table 24. Latin America Toxoid Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Toxoid Vaccines Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Toxoid Vaccines Sales by Type (2021-2026) & (US$ Million) Table 27. Toxoid Vaccines Industry Trends Table 28. Toxoid Vaccines Industry Drivers Table 29. Toxoid Vaccines Industry Opportunities and Challenges Table 30. Toxoid Vaccines Industry Restraints Table 31. Global Toxoid Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Toxoid Vaccines Revenue Market Share by Company (2021-2026) Table 33. Global Toxoid Vaccines Sales by Company (2021-2026) & (k units) Table 34. Global Toxoid Vaccines Sales Share by Company (2021-2026) Table 35. Global Toxoid Vaccines Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Toxoid Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Toxoid Vaccines Major Company Production Sites and Headquarters Table 38. Global Toxoid Vaccines Company, Product Type & Application Table 39. Global Toxoid Vaccines Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Toxoid Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Toxoid Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Toxoid Vaccines Sales by Region (2021-2026) & (k units) Table 44. Global Toxoid Vaccines Sales Market Share in Volume by Region (2021-2026) Table 45. Global Toxoid Vaccines Sales by Region (2021-2026) & (US$ Million) Table 46. Global Toxoid Vaccines Sales Market Share in Value by Region (2021-2026) Table 47. Global Toxoid Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Toxoid Vaccines Sales by Region (2027-2032) & (k units) Table 49. Global Toxoid Vaccines Sales Market Share in Volume by Region (2027-2032) Table 50. Global Toxoid Vaccines Sales by Region (2027-2032) & (US$ Million) Table 51. Global Toxoid Vaccines Sales Market Share in Value by Region (2027-2032) Table 52. Global Toxoid Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Toxoid Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Toxoid Vaccines Sales by Application (2021-2026) & (k units) Table 55. Global Toxoid Vaccines Sales Market Share in Volume by Application (2021-2026) Table 56. Global Toxoid Vaccines Sales by Application (2021-2026) & (US$ Million) Table 57. Global Toxoid Vaccines Sales Market Share in Value by Application (2021-2026) Table 58. Global Toxoid Vaccines Price by Application (2021-2026) & (US$/unit) Table 59. Global Toxoid Vaccines Sales by Application (2027-2032) & (k units) Table 60. Global Toxoid Vaccines Sales Market Share in Volume by Application (2027-2032) Table 61. Global Toxoid Vaccines Sales by Application (2027-2032) & (US$ Million) Table 62. Global Toxoid Vaccines Sales Market Share in Value by Application (2027-2032) Table 63. Global Toxoid Vaccines Price by Application (2027-2032) & (US$/unit) Table 64. North America Toxoid Vaccines Sales by Application (2021-2026) & (k units) Table 65. North America Toxoid Vaccines Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Toxoid Vaccines Sales by Application (2021-2026) & (k units) Table 67. Europe Toxoid Vaccines Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Toxoid Vaccines Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Toxoid Vaccines Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Toxoid Vaccines Sales by Application (2021-2026) & (k units) Table 71. Latin America Toxoid Vaccines Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Toxoid Vaccines Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Toxoid Vaccines Sales by Application (2021-2026) & (US$ Million) Table 74. Shenzhen Kangtai Biological Products Company Information Table 75. Shenzhen Kangtai Biological Products Business Overview Table 76. Shenzhen Kangtai Biological Products Toxoid Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Shenzhen Kangtai Biological Products Toxoid Vaccines Product Portfolio Table 78. Shenzhen Kangtai Biological Products Recent Development Table 79. Merck Company Information Table 80. Merck Business Overview Table 81. Merck Toxoid Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Merck Toxoid Vaccines Product Portfolio Table 83. Merck Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Toxoid Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Pfizer Toxoid Vaccines Product Portfolio Table 88. Pfizer Recent Development Table 89. GlaxoSmithKline Company Information Table 90. GlaxoSmithKline Business Overview Table 91. GlaxoSmithKline Toxoid Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. GlaxoSmithKline Toxoid Vaccines Product Portfolio Table 93. GlaxoSmithKline Recent Development Table 94. AstraZeneca Company Information Table 95. AstraZeneca Business Overview Table 96. AstraZeneca Toxoid Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. AstraZeneca Toxoid Vaccines Product Portfolio Table 98. AstraZeneca Recent Development Table 99. Sanofi Pasteur Company Information Table 100. Sanofi Pasteur Business Overview Table 101. Sanofi Pasteur Toxoid Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Sanofi Pasteur Toxoid Vaccines Product Portfolio Table 103. Sanofi Pasteur Recent Development Table 104. Panacea Biotec Company Information Table 105. Panacea Biotec Business Overview Table 106. Panacea Biotec Toxoid Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Panacea Biotec Toxoid Vaccines Product Portfolio Table 108. Panacea Biotec Recent Development Table 109. Emergent Biosolutions Company Information Table 110. Emergent Biosolutions Business Overview Table 111. Emergent Biosolutions Toxoid Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Emergent Biosolutions Toxoid Vaccines Product Portfolio Table 113. Emergent Biosolutions Recent Development Table 114. Bharat Biotech Company Information Table 115. Bharat Biotech Business Overview Table 116. Bharat Biotech Toxoid Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Bharat Biotech Toxoid Vaccines Product Portfolio Table 118. Bharat Biotech Recent Development Table 119. Bausch Health Company Information Table 120. Bausch Health Business Overview Table 121. Bausch Health Toxoid Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Bausch Health Toxoid Vaccines Product Portfolio Table 123. Bausch Health Recent Development Table 124. Astellas Pharma Company Information Table 125. Astellas Pharma Business Overview Table 126. Astellas Pharma Toxoid Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Astellas Pharma Toxoid Vaccines Product Portfolio Table 128. Astellas Pharma Recent Development Table 129. North America Toxoid Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 130. North America Toxoid Vaccines Sales by Country (2021-2026) & (k units) Table 131. North America Toxoid Vaccines Sales Market Share by Country (2021-2026) Table 132. North America Toxoid Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 133. North America Toxoid Vaccines Sales Market Share Forecast by Country (2027-2032) Table 134. North America Toxoid Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. North America Toxoid Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 136. North America Toxoid Vaccines Market Share by Country (2021-2026) Table 137. North America Toxoid Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. North America Toxoid Vaccines Market Share Forecast by Country (2027-2032) Table 139. Europe Toxoid Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 140. Europe Toxoid Vaccines Sales by Country (2021-2026) & (k units) Table 141. Europe Toxoid Vaccines Sales Market Share by Country (2021-2026) Table 142. Europe Toxoid Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 143. Europe Toxoid Vaccines Sales Market Share Forecast by Country (2027-2032) Table 144. Europe Toxoid Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Europe Toxoid Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 146. Europe Toxoid Vaccines Market Share by Country (2021-2026) Table 147. Europe Toxoid Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Europe Toxoid Vaccines Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Toxoid Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Toxoid Vaccines Sales by Country (2021-2026) & (k units) Table 151. Asia-Pacific Toxoid Vaccines Sales Market Share by Country (2021-2026) Table 152. Asia-Pacific Toxoid Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 153. Asia-Pacific Toxoid Vaccines Sales Market Share Forecast by Country (2027-2032) Table 154. Asia-Pacific Toxoid Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Asia-Pacific Toxoid Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 156. Asia-Pacific Toxoid Vaccines Market Share by Country (2021-2026) Table 157. Asia-Pacific Toxoid Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Asia-Pacific Toxoid Vaccines Market Share Forecast by Country (2027-2032) Table 159. Latin America Toxoid Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 160. Latin America Toxoid Vaccines Sales by Country (2021-2026) & (k units) Table 161. Latin America Toxoid Vaccines Sales Market Share by Country (2021-2026) Table 162. Latin America Toxoid Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 163. Latin America Toxoid Vaccines Sales Market Share Forecast by Country (2027-2032) Table 164. Latin America Toxoid Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Latin America Toxoid Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 166. Latin America Toxoid Vaccines Market Share by Country (2021-2026) Table 167. Latin America Toxoid Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Latin America Toxoid Vaccines Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Toxoid Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Toxoid Vaccines Sales by Country (2021-2026) & (k units) Table 171. Middle East and Africa Toxoid Vaccines Sales Market Share by Country (2021-2026) Table 172. Middle East and Africa Toxoid Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 173. Middle East and Africa Toxoid Vaccines Sales Market Share Forecast by Country (2027-2032) Table 174. Middle East and Africa Toxoid Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Middle East and Africa Toxoid Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 176. Middle East and Africa Toxoid Vaccines Market Share by Country (2021-2026) Table 177. Middle East and Africa Toxoid Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Middle East and Africa Toxoid Vaccines Market Share Forecast by Country (2027-2032) Table 179. Key Raw Materials Table 180. Raw Materials Key Suppliers Table 181. Toxoid Vaccines Distributors List Table 182. Toxoid Vaccines Customers List Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources Table 186. Primary Sources List of Figures Figure 1. Toxoid Vaccines Image Figure 2. Global Toxoid Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Toxoid Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Toxoid Vaccines Sales (2021-2032) & (k units) Figure 5. Tetanus Image Figure 6. Global Tetanus Sales YoY Growth (2021-2032) & (k units) Figure 7. Monovalent Tetanus Toxoid (TT) Image Figure 8. Global Monovalent Tetanus Toxoid (TT) Sales YoY Growth (2021-2032) & (k units) Figure 9. Pertussis (DTaP) Image Figure 10. Global Pertussis (DTaP) Sales YoY Growth (2021-2032) & (k units) Figure 11. Diphtheria and Tetanus (DT) Image Figure 12. Global Diphtheria and Tetanus (DT) Sales YoY Growth (2021-2032) & (k units) Figure 13. Diphtheria Image Figure 14. Global Diphtheria Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Toxoid Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Toxoid Vaccines Market Share by Type 2025 VS 2032 Figure 17. North America Toxoid Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. North America Toxoid Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Europe Toxoid Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Europe Toxoid Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Toxoid Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Toxoid Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Latin America Toxoid Vaccines Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Toxoid Vaccines Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Toxoid Vaccines Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Toxoid Vaccines Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Toxoid Vaccines Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Government Organizations Image Figure 30. Global Government Organizations Sales YoY Growth (2021-2032) & (k units) Figure 31. Hospitals And Clinics Image Figure 32. Global Hospitals And Clinics Sales YoY Growth (2021-2032) & (k units) Figure 33. Research Image Figure 34. Global Research Sales YoY Growth (2021-2032) & (k units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Toxoid Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Toxoid Vaccines Market Share by Application 2025 VS 2032 Figure 39. North America Toxoid Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. North America Toxoid Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Europe Toxoid Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Europe Toxoid Vaccines Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Toxoid Vaccines Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Toxoid Vaccines Sales Market Share in Value by Application in 2025 Figure 45. Latin America Toxoid Vaccines Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Toxoid Vaccines Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Toxoid Vaccines Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Toxoid Vaccines Sales Market Share in Value by Application in 2025 Figure 49. North America Toxoid Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Toxoid Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Toxoid Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Toxoid Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Toxoid Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Toxoid Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Toxoid Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Toxoid Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Toxoid Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Toxoid Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Toxoid Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Toxoid Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Toxoid Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Toxoid Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Toxoid Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Toxoid Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Toxoid Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Toxoid Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Toxoid Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Toxoid Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Toxoid Vaccines Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Toxoid Vaccines Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Tetanus
  • Monovalent Tetanus Toxoid (TT)
  • Pertussis (DTaP)
  • Diphtheria and Tetanus (DT)
  • Diphtheria
Applications
  • Government Organizations
  • Hospitals And Clinics
  • Research
  • Others
Companies covered
  • Shenzhen Kangtai Biological Products
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Sanofi Pasteur
  • Panacea Biotec
  • Emergent Biosolutions
  • Bharat Biotech
  • Bausch Health
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Toxoid Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Toxoid Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Toxoid Vaccines Market by Type
  6. 1.3.1 Tetanus
  7. 1.3.2 Monovalent Tetanus Toxoid (TT)
  8. 1.3.3 Pertussis (DTaP)
  9. 1.3.4 Diphtheria and Tetanus (DT)
  10. 1.3.5 Diphtheria
  11. 1.4 Global Toxoid Vaccines Market Size by Type
  12. 1.4.1 Global Toxoid Vaccines Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Toxoid Vaccines Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Toxoid Vaccines Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Toxoid Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Toxoid Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Toxoid Vaccines Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Toxoid Vaccines Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Toxoid Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Toxoid Vaccines Industry Trends
  2. 2.2 Toxoid Vaccines Industry Drivers
  3. 2.3 Toxoid Vaccines Industry Opportunities and Challenges
  4. 2.4 Toxoid Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Toxoid Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Toxoid Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Toxoid Vaccines Price (2021-2026)
  4. 3.4 Global Toxoid Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Toxoid Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Toxoid Vaccines Company, Product Type & Application
  7. 3.7 Global Toxoid Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Toxoid Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Toxoid Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Toxoid Vaccines Tier 1, Tier 2, and Tier 3
4 Toxoid Vaccines Regional Status and Outlook
  1. 4.1 Global Toxoid Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Toxoid Vaccines Historic Market Size by Region
  3. 4.2.1 Global Toxoid Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Toxoid Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Toxoid Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Toxoid Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Toxoid Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Toxoid Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Toxoid Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Toxoid Vaccines by Application
  1. 5.1 Toxoid Vaccines Market by Application
  2. 5.1.1 Government Organizations
  3. 5.1.2 Hospitals And Clinics
  4. 5.1.3 Research
  5. 5.1.4 Others
  6. 5.2 Global Toxoid Vaccines Market Size by Application
  7. 5.2.1 Global Toxoid Vaccines Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Toxoid Vaccines Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Toxoid Vaccines Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Toxoid Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Toxoid Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Toxoid Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Toxoid Vaccines Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Toxoid Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shenzhen Kangtai Biological Products
  2. 6.1.1 Shenzhen Kangtai Biological Products Company Information
  3. 6.1.2 Shenzhen Kangtai Biological Products Business Overview
  4. 6.1.3 Shenzhen Kangtai Biological Products Toxoid Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shenzhen Kangtai Biological Products Toxoid Vaccines Product Portfolio
  6. 6.1.5 Shenzhen Kangtai Biological Products Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Toxoid Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Toxoid Vaccines Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Toxoid Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Toxoid Vaccines Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline Toxoid Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline Toxoid Vaccines Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Toxoid Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Toxoid Vaccines Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Sanofi Pasteur
  32. 6.6.1 Sanofi Pasteur Company Information
  33. 6.6.2 Sanofi Pasteur Business Overview
  34. 6.6.3 Sanofi Pasteur Toxoid Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sanofi Pasteur Toxoid Vaccines Product Portfolio
  36. 6.6.5 Sanofi Pasteur Recent Developments
  37. 6.7 Panacea Biotec
  38. 6.7.1 Panacea Biotec Company Information
  39. 6.7.2 Panacea Biotec Business Overview
  40. 6.7.3 Panacea Biotec Toxoid Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Panacea Biotec Toxoid Vaccines Product Portfolio
  42. 6.7.5 Panacea Biotec Recent Developments
  43. 6.8 Emergent Biosolutions
  44. 6.8.1 Emergent Biosolutions Company Information
  45. 6.8.2 Emergent Biosolutions Business Overview
  46. 6.8.3 Emergent Biosolutions Toxoid Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Emergent Biosolutions Toxoid Vaccines Product Portfolio
  48. 6.8.5 Emergent Biosolutions Recent Developments
  49. 6.9 Bharat Biotech
  50. 6.9.1 Bharat Biotech Company Information
  51. 6.9.2 Bharat Biotech Business Overview
  52. 6.9.3 Bharat Biotech Toxoid Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bharat Biotech Toxoid Vaccines Product Portfolio
  54. 6.9.5 Bharat Biotech Recent Developments
  55. 6.10 Bausch Health
  56. 6.10.1 Bausch Health Company Information
  57. 6.10.2 Bausch Health Business Overview
  58. 6.10.3 Bausch Health Toxoid Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bausch Health Toxoid Vaccines Product Portfolio
  60. 6.10.5 Bausch Health Recent Developments
  61. 6.11 Astellas Pharma
  62. 6.11.1 Astellas Pharma Company Information
  63. 6.11.2 Astellas Pharma Business Overview
  64. 6.11.3 Astellas Pharma Toxoid Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Astellas Pharma Toxoid Vaccines Product Portfolio
  66. 6.11.5 Astellas Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Toxoid Vaccines Sales by Country
  2. 7.1.1 North America Toxoid Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Toxoid Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Toxoid Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Toxoid Vaccines Market Size by Country
  6. 7.2.1 North America Toxoid Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Toxoid Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Toxoid Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Toxoid Vaccines Sales by Country
  2. 8.1.1 Europe Toxoid Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Toxoid Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Toxoid Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Toxoid Vaccines Market Size by Country
  6. 8.2.1 Europe Toxoid Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Toxoid Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Toxoid Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Toxoid Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Toxoid Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Toxoid Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Toxoid Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Toxoid Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Toxoid Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Toxoid Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Toxoid Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Toxoid Vaccines Sales by Country
  2. 10.1.1 South America Toxoid Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Toxoid Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Toxoid Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Toxoid Vaccines Market Size by Country
  6. 10.2.1 South America Toxoid Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Toxoid Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Toxoid Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Toxoid Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Toxoid Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Toxoid Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Toxoid Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Toxoid Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Toxoid Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Toxoid Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Toxoid Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Toxoid Vaccines Value Chain Analysis
  2. 12.1.1 Toxoid Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Toxoid Vaccines Production Mode & Process
  7. 12.2 Toxoid Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Toxoid Vaccines Distributors
  10. 12.2.3 Toxoid Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst